BOVILIS Cavalry 9

This treatment applies to the following species:

Company: Intervet/Merck Animal Health

Clostridium Chauvoei-Septicum-Haemolyticum-Novyi-Sordellii-Tetani-Perfringens Types C & D Bacterin-Toxoid

Cattle Vaccine

BOVILIS Cavalry 9 Indications

This product has been shown to be effective for the vaccination of healthy cattle against disease caused by Clostridium chauvoei, C. septicum, C. haemolyticum, C. novyi, C. sordellii, C. tetani, and C. perfringens Types C & D. This product was licensed prior to the requirement to establish a minimum age for use. Duration of immunity has not been established. For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov.

Although C. perfringens Type B is not a significant problem in North America, immunity is derived from a combination of the Type C (beta) and Type D (epsilon) fractions.

ADMINISTRATION AND DOSAGE: Mix gently. Inject 2 mL subcutaneously followed by a 2 mL dose in 3 weeks. Calves vaccinated at 3-6 months of age should be given a 3rd vaccination with either this vaccine, or another vaccine containing C. perfringens Type D epsilon toxoid. For advice on revaccination frequency, contact your veterinarian.

PRESERVATIVES: Gentamicin and thimerosal.

Precautions

This product has been tested under laboratory conditions and shown to meet all Federal standards for safety and efficacy. This level of performance may be affected by conditions of use such as stress, weather, nutrition, disease, parasitism, other treatments, individual idiosyncrasies or impaired immunological competency. These factors should be considered by the user when evaluating product performance or freedom from reactions.

Transient swelling may occur post-vaccination.

BOVILIS Cavalry 9 Caution

Store at 2°-8°C (35°-46°F). Do not freeze. Use entire contents when first opened. Do not mix with other products. Do not vaccinate within 21 days before slaughter. This product has not been tested in pregnant animals. Anaphylactoid reactions may occur following use. Antidote: Epinephrine. In case of human exposure, contact a physician.

FOR ANIMAL USE ONLY.

Manufactured by

Schering-Plough Animal Health Limited, Upper Hutt, New Zealand

Distributed by

Intervet Inc. d/b/a Merck Animal Health, Omaha, NE 68103 USA

VLN 311/PCN 7340.00

1 800 521-5767 (USA)

For patent information:

http://www.merck.com/product/patent/home.html

			Code
250 mL	125 Doses	2 mL per dose	067694	393962 R8

CPN: 1047284.3

MERCK ANIMAL HEALTH
Intervet Inc.
126 E. LINCOLN AVENUE, PO BOX 2000, Rahway, NJ, 07065

Customer Service:		800-521-5767
Technical Service (Companion Animal):		800-224-5318
Technical Service (Livestock):		800-211-3573
Website:		www.merck-animal-health-usa.com

THIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details.